EMERGENT BIOSOLUTIONS INC. (EBS) scores 39 out of 100 on boothcheck's 11-model valuation framework. Verdict: Bad The estimated fair value is 14.58, representing a 74% margin of safety. Quantitative score: 53/100. Qualitative score: 30/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.